Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 1/20 | 0.30 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4026070 | 0.90 | — | — | |
| SCHEMBL4019568 | 0.80 | ALDH1A1 (0.33) | — | |
| SCHEMBL2163809 | 0.75 | ALDH1A1 (0.32) | — | |
| SCHEMBL4017133 | 0.72 | ALDH1A1 (0.30) | — | |
| SCHEMBL2002342 | 0.70 | — | — | |
| SCHEMBL4022412 | 0.69 | ALDH1A1 (0.43) | ADRA2AADRA1DADRA1AADRA1B | |
| SCHEMBL4024401 | 0.69 | — | — | |
| SCHEMBL6654000 | 0.63 | — | — | |
| SCHEMBL9577261 | 0.62 | — | — | |
| SCHEMBL9981136 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090200524-A1 | ORGANOMETALLIC COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND METHODS OF USE THEREOF | PRAXAIR TECHNOLOGY, INC. | 2009-08-13 | — | — | US | claimed |
| US-20090203917-A1 | ORGANOMETALLIC COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND METHODS OF USE THEREOF | PRAXAIR TECHNOLOGY, INC. | 2009-08-13 | — | — | US | claimed |
| US-20090202740-A1 | ORGANOMETALLIC COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND METHODS OF USE THEREOF | PRAXAIR TECHNOLOGY, INC. | 2009-08-13 | — | — | US | claimed |
| WO-2009094259-A1 | ORGANOMETALLIC COMPOUNDS PROCESSES AND METHODS OF USE | PRAXAIR TECHNOLOGY, INC. (US) | 2009-07-30 | — | — | WO | claimed |
| US-20090202740-A1 | ORGANOMETALLIC COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND METHODS OF USE THEREOF | PRAXAIR TECHNOLOGY, INC. | 2009-08-13 | — | — | US | disclosed |
| US-20090200524-A1 | ORGANOMETALLIC COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND METHODS OF USE THEREOF | PRAXAIR TECHNOLOGY, INC. | 2009-08-13 | — | — | US | disclosed |
| US-20090203917-A1 | ORGANOMETALLIC COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND METHODS OF USE THEREOF | PRAXAIR TECHNOLOGY, INC. | 2009-08-13 | — | — | US | disclosed |
| WO-2009094259-A1 | ORGANOMETALLIC COMPOUNDS PROCESSES AND METHODS OF USE | PRAXAIR TECHNOLOGY, INC. (US) | 2009-07-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203917-A1 | ORGANOMETALLIC COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND METHODS OF USE THEREOF | L1CAM, TLL2, LANCL2 | ADRA2A 3945/4885ADRA1D 4655/4885ADRA1A 4671/4885 |
| US-20090200524-A1 | ORGANOMETALLIC COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND METHODS OF USE THEREOF | L1CAM, TLL2, LANCL2 | ADRA2A 3945/4885ADRA1D 4655/4885ADRA1A 4671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.